SlideShare ist ein Scribd-Unternehmen logo
1 von 20
Downloaden Sie, um offline zu lesen
George Mattathil -
5/17/2011




Let’s Build A Smarter Planet:
What will it mean for Life Sciences?




                                       © 2010 IBM Corporation
The reality of living in a globally integrated world is upon us.



 Safety, quality, efficacy of products is challenged more than ever before

 Outdated and inefficient (drug) research and development (R&D) has contributed
  to expiring patents, dry pipelines and cost

 Generic alternatives abound as pricing pressures increase

 Globalization efforts and the new economic environment have
  constrained resources


The world is connected:
economically, socially and technically.




                                                                              © 2010 IBM Corporation
The need for progress is clear.




               50%                                                                         65.2 billion
                of patients drop out of their                                               Dollars invested in US pharma
                treatment within the first                                                  and biotech R&D in 2008. Only 4
                year.20% of prescriptions go                                                truly innovative products were
                unfilled in hard economic times                                             delivered in the same period.2
                and 30% of prescriptions are
                not refilled.1


               90%                                                                          74 billion
                of drugs work in only                                                        Dollars US lost due to
                30-50% of people3                                                            a 10% counterfeit
                                                                                             drug supply4
1 ―ECONOMIC CRISIS : Pharma Sales Will Drop As Patients Cut Back on Prescriptions‖
2 R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges, March 10, 2009
3 ―Demolished - the myth that allows drugs giants to sell more‖. , The Independent, Dec. 8, 2003.
4 ―Partnership for Safe Medicines Arms Public Against Counterfeit Drugs‖ Dec. 2, 2008 and IBM analysis

                                                                                                                               © 2010 IBM Corporation
The opportunity for progress is clear.

Better compliance with treatment                            More innovative discovery
                                                            & development
Smarter Life Sciences:                                      Smarter Life Sciences:
Merit Foundation                                            Ecole Polytechnique Federale de Lausanne

A Netherlands based non-commercial, international           A major Swiss research institute harnesses the
medical organization accesses thousands of                  power of supercomputers to model the human brain,
anonymous patient records and monitors patients’            speeding the search for causes and cures of
progress and benchmark responses to treatment               neurological and psychiatric diseases with the ability
against information about others                            to run simulations in close to real time

Improved patient insights                                   Reduced risk from counterfeits

Smarter Life Sciences:                                      Smarter Life Sciences:
Metabasis therapeutics, Inc.                                GSMS, Inc.

A biopharmaceutical company in the U.S.                     A small U.S. wholesale pharmaceuticals distributor,
speeds time to market for metabolic- and liver-             contract manufacturer and packaging company
disease therapies                                           deploys a pharmaceutical track and trace solution
                                                            ahead of the competition
The demand for change is strong
The 2008 Global CEO Study: ―The Enterprise of the Future‖

                                                                                                     © 2010 IBM Corporation
The demand for change is strong.

                          LIFE SCIENCES CEO’S   GLOBAL CEO’S




8 in 10
Life Sciences leaders
anticipate substantial
change ahead.




22%
Gap between envisioned
change and past success
at managing it.

Change Needed




                                                               © 2010 IBM Corporation
For life sciences companies, this means leading in the face of
global challenges brought on by three key drivers while overcoming
two key inhibitors.

DRIVERS                                         INHIBITORS

BETTER UNDERSTANDING OF THE                     COST AND REVENUE PRESSURES
FUNDAMENTALS OF THE DISEASE                     GROWING RAPIDLY
Predictability of a treatment’s efficacy and    Restructured business models to
safety will drive improved outcomes             streamline overall operations including
                                                strategic outsourcing, partnering and
                                                turning to emerging markets
PRODUCT MODELS MOVE TO BIOLOGICS
Drugs targeted at a defined population
as well as disease-modifying and preventative   REGULATORY, POLITICAL AND SOCIETAL
in nature                                       PRESSURES INTENSIFYING
                                                Legislation is forcing investments in
                                                supply chain traceability and promotional
DISRUPTIVE SCIENCE AND                          spending analysis
TECHNOLOGY EMERGING
Increased use of medical imaging and
biomarkers in the move to targeted treatments
and personalized medicine



                                                                                          © 2010 IBM Corporation
A smarter system forges partnerships in order to deliver
treatment solutions which are targeted at the individual patient.



                                     Smarter Discovery
                                      & Development

Collaboration with                                                  People and the
 Other life sciences                                                organization
  companies                           Smarter life                  Technology
 Biotech                               sciences                    Processes
 Medical device                      organization
                          Smarter                        Smarter
  and diagnostic          Sales &                        Supply
  manufacturers          Marketing                        Chain     Enhanced
 Contract                                                           communication with
  organizations                                                      end consumer
 Academic centers                                                  Compliance
 Hospitals / clinics                                               Patient persistence
 Patients                                                          Consumer insights
                                      Network of
                                     smart partners


                                Patient / consumer
                                     insights



                                                                        © 2010 IBM Corporation
It’s a new world—and life sciences organizations are key players
in an economy that demands increased value, safer solutions, better
outcomes, sustainability and accountability.



                      INNOVATE                                         OPERATE EFFECTIVELY
 Develop new business models to                                        Align and optimize processes to
   compete more effectively. Fuel                                      support patient centered healthcare
      innovation in R&D and drive                                      delivery and patient safety to drive
    greater discovery productivity.                                    better outcomes and an enhanced
                                         LIFE                          experience.
                                       SCIENCES




                                      ENGAGE
                                      Enable life sciences to take an active
                                      role in empower a healthier society and
                                      patients by collaborating to improve
                                      breakthrough therapies.

                                                                                            © 2010 IBM Corporation
+                +           =
       An opportunity for life science organizations
             to think and act in new ways.

Innovate          Operate Effectively             Engage




                                                       © 2010 IBM Corporation
Smart life sciences:
Innovate.


SMART IS                                     SMART IS
Improving the efficiency of drug discovery   Reducing attrition rates and costs
and development through to reformulation     during discovery by use of high
of existing drug products to extend          performance computing.
product life cycle.




SMART IS                                     SMART IS
Fueling clinical innovation with much        Integrating all relevant data, reproducing
more processing power while                  the control principles of a biological
decreasing operating costs.                  system and simulating how it
                                             will respond.




                                                                             © 2010 IBM Corporation
Smart life sciences:
Operate Effectively.


SMART IS                                  SMART IS
Combating risk by building                Automating baseline activities in the
intelligence into both products           supply chain increases responsiveness to
and packaging.                            free up time for employees to manage
                                          critical exceptions and focus on higher
                                          value activities.




SMART IS                                  SMART IS
Automatically analyzing and correlating   Enabling research beyond the current
information from multiple sources to      ―trial, file, and archive‖ data usage model
identify areas of risk and regulatory     through clinical & safety data accessible
compliance exposures.                     across studies.




                                                                          © 2010 IBM Corporation
Smart life sciences:
Engage.


SMART IS                                       SMART IS
Driving more innovation and short term         Identifying actions to stem the impact
revenues through collaboration.                of chronic diseases like diabetes, heart
                                               disease or stroke by modeling
                                               disease progression.




SMART IS                                       SMART IS
Monitoring impending disasters and
                                               Building in interconnectivity across a
proactively responding so supply of
                                               network to provide a hands-on view of
targeted treatment is available immediately.
                                               the entire supply chain for all parties.




                                                                               © 2010 IBM Corporation
Smart life sciences:


Innovate.                                                        Engage.




Ecole Polytechnique Federale de Lausanne (EPFL):                 Merit Foundation: developed METEOR – Measurement of
Embarked on Project Blue Brain, a joint research venture         Efficacy of Treatment in the Era of Outcome in
with IBM to create a model of the fundamental building           Rheumatology – an Internet-based solution that will
blocks of the human brain, unprecedented in its scope –          revolutionize and improve patient treatment. Clinicians now
ultimately generating functional models for 10,000               have access to thousands of anonymous patient records,
morphologically complex neurons.                                 covering several countries and many hospitals; they can
                                                                 learn from one another on the best treatment for patients.
Innovate.Engage.



National Genographic: created a DNA analysis repository that lets researchers and scientists analyze gathered genetic
data and identify patterns among the samples. Private citizens can also contribute samples to the DNA repository, hosted in
an IBM DB2® data server, and view personalized ancestral migration profiles on the organization’s Web site. This has
Establishes one of the largest centralized collections of genetic information, increasing collaboration among scientists
and researchers.

                                                                                                               © 2010 IBM Corporation
Operate Effectively.




Metabasis Therapeutics: Highly-accurate, first-of-a-   Golden State Medical Supply, Inc. (GSMS):
kind simulation software significantly lowers drug     Implemented the Pharma Track & Trace Solution using
discovery time and costs by eliminating 80% of the     two-dimensional barcodes, radio frequency
compounds to be synthesized and tested in the lab.1    identification (RFID) and other sensors to track
                                                       product movements. Puts GSMS in an advantageous
                                                       competitive position by making it one of the first
                                                       distributors to comply with the new regulations.




Fujita Pharmaceutical LTD, Co. : Improved its total    Bilcare Limited: Developed a Track-and-Trace
project management capabilities. The new solution      Solution framework to seamlessly integrated into any
helps the company minimize out-of-stock instances      supply chain system, providing real-time product
by consistently managing sales, production,            authentication. The technology helps detect
purchases of raw materials and accounting through a    counterfeit goods, potentially saving millions of lives
single system.
                                                                                                       © 2010 IBM Corporation
Smart life sciences: IBM Research Projects



New Intelligence Research Example                    Smart Work Research Example




Protecting the privacy of biometric data by          Leveraging Blue Gene for large scale simulation
creating an anonymous biometrics recognition         in the drug discovery process.
system that scales to large populations.

Dynamic Infrastructure Research Examples




Automatically analyzing and correlating              Building governance and maintenance tools to
information from multiple sources to identify        support benefit configuration, research, and
areas of risk and regulatory compliance exposures.   correction processes.

                                                                                          © 2010 IBM Corporation
At the center of smarter life sciencesis an increasingly more
networked operation focused on the end patient.
                        IMPROVING         COLLABORATING
                 operations internally    with other biophamra, academia



       MEASURING
       your progress                                     SHARING                IMPROVED PATIENT
            and plan                                     patient insights
                                                                                 INSIGHTS

                                                                                REDUCED RISK
                                                                                 FROM COUNTERFEITS
     COMPLYING
   with regulations                                                             BETTER COMPLIANCE
                                                                                 WITH TREATMENT

                                                                                MORE INNOVATIVE
       MONITORING                                         UNDERSTANDING          DISCOVERY &
      and responding                                      fundamental of the     DEVELOPMENT
            to signals
                                                          disease

                       CONVERGING         INTEGRATING
                      across industries   all relevant data both
                                          internally and externally


The result is also a safe, effective and valued treatment
solution targeted at the patient.
                                                                                            © 2010 IBM Corporation
The imperative for life sciences today is clear.



INNOVATE                        OPERATE EFFECTIVELY                   ENGAGE
 Develop strategies in          Optimize core systems and            Interconnect researchers
  support of advanced             infrastructure to reduce costs        from academic, industry and
  therapies and technologies,     and to more flexibly service          regulators to bolster product
  such as gene and cell           new business demands                  pipelines
  therapies and
                                 Use technology to                    Bridge internal silos with
  nanotechnology
                                  communicate, share information        better collaboration tools and
 Fuel drug discovery by          and assist in decision-support        infrastructures
  investing in innovative
                                 Employ a fact-based,                 Build an integrated network
  decision-making
                                  quantitative risk management          of manufacturing, and
  approaches
                                  approach in the supply chain          distribution partners
 Maximize development with       and by building intelligence into
  the integration of modeling     products and packaging
  and simulation into new
  clinical trial programs
 Use social networking to
  connect globally to gather
  insights to fuel innovation

                                                                                          © 2010 IBM Corporation
IBM’s solution strategy is aligned with the needs
of all stakeholders of the life sciences companies.


 LIFE SCIENCES SYSTEMS ARE FOCUSED ON…                IBM IS INVESTING IN…

                                            Systems biology
     Innovate and thrive
                                            Nanotechnology
                                            Smarter Analytics & Information Agenda
                                            Clinical decision support systems
                                            Customer segmentation / e-detailing
                                            Business process modeling, analytics and performance
                                             management
                                            Life Sciences Hub
                                            Biopartnering strategy
                                            Interoperability
     Streamline and transform               Medical home: Patient-centered collaborative care
                                            Patient portals
                                            Collaborative platforms & tools
                                            Risk Modeling
                                            Universal Data Model/Warehouse
     Collaborate and empower                The New Pharma Commercial Model
                                            Marketing and Sales
                                            Regulatory Compliance
                                            Pharmacoviligence
                                            Content Management
                                            Pharma Track and Trace


                                                                                 © 2010 IBM Corporation
We’ve only just begun
to uncover what is possible on
a smarter planet.

 The world will continue to become smaller, flatter
  and smarter. We are moving into the age of the
  globally integrated and intelligent economy, society
  and planet.
 To thrive in a smarter planet, life sciences
  organizations need to transform so they are more
  streamlined internally and collaborating effectively
  externally to deliver more innovative products.
  There’s no better time to start building a smarter life
  sciences industry to provide more patient-centric
  treatment for society.

Let’s work together to drive
real progress in our world.
                                             © 2010 IBM Corporation
Trademarks and notes



   IBM Corporation 2009


    IBM, the IBM logo and ibm.com are registered trademarks, and other company, product or
     service names may be trademarks or service marks of International Business Machines
     Corporation in the United States, other countries, or both. A current list of IBM trademarks is
     available on the Web at ―Copyright and trademark information‖ at
     www.ibm.com/legal/copytrade.shtml
    Adobe, the Adobe logo, PostScript, the PostScript logo, Cell Broadband Engine, Intel, the
     Intel logo, Intel Inside, the Intel Inside logo, Intel Centrino, the Intel Centrino logo, Celeron,
     Intel Xeon, Intel SpeedStep, Itanium, IT Infrastructure Library, ITIL, Java and all Java-based
     trademarks, Linux, Microsoft, Windows, Windows NT, the Windows logo, and UNIX are
     trademarks or service marks of others as described under ―Special attributions‖ at:
     http://www.ibm.com/legal/copytrade.shtml#section-special
    Other company, product and service names may be trademarks or service marks of others.
    References in this publication to IBM products or services do not imply that IBM intends to
     make them available in all countries in which IBM operates.




                                                                                                 © 2010 IBM Corporation

Weitere ähnliche Inhalte

Was ist angesagt?

Big data cloud cloud circle keynote_final laura colvine 8th november 2012
Big data cloud cloud circle keynote_final laura colvine 8th november 2012Big data cloud cloud circle keynote_final laura colvine 8th november 2012
Big data cloud cloud circle keynote_final laura colvine 8th november 2012IBM
 
I-Bytes Technology Industry
I-Bytes Technology IndustryI-Bytes Technology Industry
I-Bytes Technology IndustryEGBG Services
 
Pm Intro (Blk)
Pm Intro (Blk)Pm Intro (Blk)
Pm Intro (Blk)cramini
 
CliMetrics | Best Practices Webinar Jan 25, 2012
CliMetrics | Best Practices Webinar Jan 25, 2012CliMetrics | Best Practices Webinar Jan 25, 2012
CliMetrics | Best Practices Webinar Jan 25, 2012wrnorris
 
Smarter Planet: Dynamic Infrastructure
Smarter Planet: Dynamic InfrastructureSmarter Planet: Dynamic Infrastructure
Smarter Planet: Dynamic InfrastructureIBMAsean
 
Esg emc-customer-service-072012
Esg emc-customer-service-072012Esg emc-customer-service-072012
Esg emc-customer-service-072012ryand24
 
Groot Group Corporate Presentation 2011
Groot Group Corporate Presentation 2011Groot Group Corporate Presentation 2011
Groot Group Corporate Presentation 2011Simon Kapenda
 
Value chain innovation - Breaking the chains
Value chain innovation - Breaking the chainsValue chain innovation - Breaking the chains
Value chain innovation - Breaking the chainsJurjen Helmus
 
Infosys corporate presentation (it industry) samz
Infosys corporate presentation (it industry)   samzInfosys corporate presentation (it industry)   samz
Infosys corporate presentation (it industry) samzBobby Dhoni
 
Mobilizing the Enterprise
Mobilizing the EnterpriseMobilizing the Enterprise
Mobilizing the EnterpriseCognizant
 
Enterprise mobility unplugged indian perspective, http://www.technology-strat...
Enterprise mobility unplugged indian perspective, http://www.technology-strat...Enterprise mobility unplugged indian perspective, http://www.technology-strat...
Enterprise mobility unplugged indian perspective, http://www.technology-strat...Devendra Prasad
 
SVUH Support Case Study
SVUH Support Case StudySVUH Support Case Study
SVUH Support Case Studynmullen
 
Logicalis Annual Review 2011
Logicalis Annual Review 2011Logicalis Annual Review 2011
Logicalis Annual Review 2011Logicalis
 

Was ist angesagt? (18)

Big data cloud cloud circle keynote_final laura colvine 8th november 2012
Big data cloud cloud circle keynote_final laura colvine 8th november 2012Big data cloud cloud circle keynote_final laura colvine 8th november 2012
Big data cloud cloud circle keynote_final laura colvine 8th november 2012
 
I-Bytes Technology Industry
I-Bytes Technology IndustryI-Bytes Technology Industry
I-Bytes Technology Industry
 
Paper-III
Paper-IIIPaper-III
Paper-III
 
Health Check Brochure
Health Check BrochureHealth Check Brochure
Health Check Brochure
 
Pm Intro (Blk)
Pm Intro (Blk)Pm Intro (Blk)
Pm Intro (Blk)
 
CliMetrics | Best Practices Webinar Jan 25, 2012
CliMetrics | Best Practices Webinar Jan 25, 2012CliMetrics | Best Practices Webinar Jan 25, 2012
CliMetrics | Best Practices Webinar Jan 25, 2012
 
The CIO Handbook
The CIO HandbookThe CIO Handbook
The CIO Handbook
 
Smarter Planet: Dynamic Infrastructure
Smarter Planet: Dynamic InfrastructureSmarter Planet: Dynamic Infrastructure
Smarter Planet: Dynamic Infrastructure
 
Esg emc-customer-service-072012
Esg emc-customer-service-072012Esg emc-customer-service-072012
Esg emc-customer-service-072012
 
Groot Group Corporate Presentation 2011
Groot Group Corporate Presentation 2011Groot Group Corporate Presentation 2011
Groot Group Corporate Presentation 2011
 
Value chain innovation - Breaking the chains
Value chain innovation - Breaking the chainsValue chain innovation - Breaking the chains
Value chain innovation - Breaking the chains
 
Infosys corporate presentation (it industry) samz
Infosys corporate presentation (it industry)   samzInfosys corporate presentation (it industry)   samz
Infosys corporate presentation (it industry) samz
 
C0452022313
C0452022313C0452022313
C0452022313
 
Chenoa Brochure
Chenoa BrochureChenoa Brochure
Chenoa Brochure
 
Mobilizing the Enterprise
Mobilizing the EnterpriseMobilizing the Enterprise
Mobilizing the Enterprise
 
Enterprise mobility unplugged indian perspective, http://www.technology-strat...
Enterprise mobility unplugged indian perspective, http://www.technology-strat...Enterprise mobility unplugged indian perspective, http://www.technology-strat...
Enterprise mobility unplugged indian perspective, http://www.technology-strat...
 
SVUH Support Case Study
SVUH Support Case StudySVUH Support Case Study
SVUH Support Case Study
 
Logicalis Annual Review 2011
Logicalis Annual Review 2011Logicalis Annual Review 2011
Logicalis Annual Review 2011
 

Andere mochten auch (11)

IBM
IBMIBM
IBM
 
Let’s build a smarter planet smarter water management
Let’s build a smarter planet smarter water managementLet’s build a smarter planet smarter water management
Let’s build a smarter planet smarter water management
 
The IBM Software Story (2)
The IBM Software Story (2)The IBM Software Story (2)
The IBM Software Story (2)
 
Business Optimization Thru Information Analytics
Business Optimization Thru Information AnalyticsBusiness Optimization Thru Information Analytics
Business Optimization Thru Information Analytics
 
Smarter Planet: Government - Public Safety
Smarter Planet: Government - Public SafetySmarter Planet: Government - Public Safety
Smarter Planet: Government - Public Safety
 
IBM Global Financing
IBM Global FinancingIBM Global Financing
IBM Global Financing
 
IBM zEnterprise: Government
IBM zEnterprise: GovernmentIBM zEnterprise: Government
IBM zEnterprise: Government
 
IBM Software Story
IBM Software StoryIBM Software Story
IBM Software Story
 
IBM Overview
IBM OverviewIBM Overview
IBM Overview
 
IBM's Transformation Journey
IBM's Transformation JourneyIBM's Transformation Journey
IBM's Transformation Journey
 
IBM Presentation
IBM PresentationIBM Presentation
IBM Presentation
 

Ähnlich wie Smarter Planet: Life Sciences

Microsoft Power Point Megatrends Asia
Microsoft Power Point   Megatrends AsiaMicrosoft Power Point   Megatrends Asia
Microsoft Power Point Megatrends Asiafrost and sullivan
 
Ibminnovationlifesciences 150601055911-lva1-app6891
Ibminnovationlifesciences 150601055911-lva1-app6891Ibminnovationlifesciences 150601055911-lva1-app6891
Ibminnovationlifesciences 150601055911-lva1-app6891Heather Fraser
 
Reinventing Life Sciences: How emerging ecosystems fuel innovation
Reinventing Life Sciences: How emerging ecosystems fuel innovationReinventing Life Sciences: How emerging ecosystems fuel innovation
Reinventing Life Sciences: How emerging ecosystems fuel innovationIBM in Healthcare
 
Accountability in Healthcare: Collaboration and Analytics are Key
Accountability in Healthcare: Collaboration and Analytics are KeyAccountability in Healthcare: Collaboration and Analytics are Key
Accountability in Healthcare: Collaboration and Analytics are KeyBukmarker
 
Eco friendly: The emerging life sciences ecosystem
Eco friendly: The emerging life sciences ecosystem    Eco friendly: The emerging life sciences ecosystem
Eco friendly: The emerging life sciences ecosystem Heather Fraser
 
Stratified and Personalised Medicine
Stratified and Personalised MedicineStratified and Personalised Medicine
Stratified and Personalised MedicineEuroBioForum
 
Life sciences areas
Life sciences areasLife sciences areas
Life sciences areasDivig Sethi
 
Life sciences areas
Life sciences areasLife sciences areas
Life sciences areasDivig Sethi
 
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdfinsightscare
 
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdfinsightssuccess2
 
Using technology-enabled social prescriptions to disrupt healthcare
Using technology-enabled social prescriptions to disrupt healthcareUsing technology-enabled social prescriptions to disrupt healthcare
Using technology-enabled social prescriptions to disrupt healthcareDr Sven Jungmann
 
TissueBiologics_SectorLandscape_2015
TissueBiologics_SectorLandscape_2015TissueBiologics_SectorLandscape_2015
TissueBiologics_SectorLandscape_2015Bridget Wall
 
1 3 Innovation Kirschbaum
1 3 Innovation Kirschbaum1 3 Innovation Kirschbaum
1 3 Innovation KirschbaumSilja Chouquet
 
The Digital Metamorphosis of the Pharma Industry
The Digital Metamorphosis of the Pharma IndustryThe Digital Metamorphosis of the Pharma Industry
The Digital Metamorphosis of the Pharma IndustryLen Starnes
 
Passing the healthcare innovation torch: from medicinal chemistry, though bio...
Passing the healthcare innovation torch: from medicinal chemistry, though bio...Passing the healthcare innovation torch: from medicinal chemistry, though bio...
Passing the healthcare innovation torch: from medicinal chemistry, though bio...Martin Sumner-Smith
 
2012 EY Biotech Report
2012 EY Biotech Report2012 EY Biotech Report
2012 EY Biotech ReportGautam Jaggi
 
How AI and Machine Learning can improve patient access to orphan drugs.pptx
How AI and Machine Learning can improve patient access to orphan drugs.pptxHow AI and Machine Learning can improve patient access to orphan drugs.pptx
How AI and Machine Learning can improve patient access to orphan drugs.pptxVidyaBreeveldDwarkas
 

Ähnlich wie Smarter Planet: Life Sciences (20)

Microsoft Power Point Megatrends Asia
Microsoft Power Point   Megatrends AsiaMicrosoft Power Point   Megatrends Asia
Microsoft Power Point Megatrends Asia
 
Ibminnovationlifesciences 150601055911-lva1-app6891
Ibminnovationlifesciences 150601055911-lva1-app6891Ibminnovationlifesciences 150601055911-lva1-app6891
Ibminnovationlifesciences 150601055911-lva1-app6891
 
Reinventing Life Sciences: How emerging ecosystems fuel innovation
Reinventing Life Sciences: How emerging ecosystems fuel innovationReinventing Life Sciences: How emerging ecosystems fuel innovation
Reinventing Life Sciences: How emerging ecosystems fuel innovation
 
Accountability in Healthcare: Collaboration and Analytics are Key
Accountability in Healthcare: Collaboration and Analytics are KeyAccountability in Healthcare: Collaboration and Analytics are Key
Accountability in Healthcare: Collaboration and Analytics are Key
 
Eco friendly: The emerging life sciences ecosystem
Eco friendly: The emerging life sciences ecosystem    Eco friendly: The emerging life sciences ecosystem
Eco friendly: The emerging life sciences ecosystem
 
Stratified and Personalised Medicine
Stratified and Personalised MedicineStratified and Personalised Medicine
Stratified and Personalised Medicine
 
Medtronic valuation
Medtronic valuationMedtronic valuation
Medtronic valuation
 
Medtronic valuation
Medtronic valuationMedtronic valuation
Medtronic valuation
 
Life sciences areas
Life sciences areasLife sciences areas
Life sciences areas
 
Life sciences areas
Life sciences areasLife sciences areas
Life sciences areas
 
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
 
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
10 Best Healthcare Companies in Australia & New Zealand 2023V3 1.pdf
 
Using technology-enabled social prescriptions to disrupt healthcare
Using technology-enabled social prescriptions to disrupt healthcareUsing technology-enabled social prescriptions to disrupt healthcare
Using technology-enabled social prescriptions to disrupt healthcare
 
TissueBiologics_SectorLandscape_2015
TissueBiologics_SectorLandscape_2015TissueBiologics_SectorLandscape_2015
TissueBiologics_SectorLandscape_2015
 
1 3 Innovation Kirschbaum
1 3 Innovation Kirschbaum1 3 Innovation Kirschbaum
1 3 Innovation Kirschbaum
 
The Digital Metamorphosis of the Pharma Industry
The Digital Metamorphosis of the Pharma IndustryThe Digital Metamorphosis of the Pharma Industry
The Digital Metamorphosis of the Pharma Industry
 
Passing the healthcare innovation torch: from medicinal chemistry, though bio...
Passing the healthcare innovation torch: from medicinal chemistry, though bio...Passing the healthcare innovation torch: from medicinal chemistry, though bio...
Passing the healthcare innovation torch: from medicinal chemistry, though bio...
 
2012 EY Biotech Report
2012 EY Biotech Report2012 EY Biotech Report
2012 EY Biotech Report
 
How AI and Machine Learning can improve patient access to orphan drugs.pptx
How AI and Machine Learning can improve patient access to orphan drugs.pptxHow AI and Machine Learning can improve patient access to orphan drugs.pptx
How AI and Machine Learning can improve patient access to orphan drugs.pptx
 
Genentech
GenentechGenentech
Genentech
 

Mehr von Strategy Advisory Group (14)

Smarter Planet: Rail
Smarter Planet: RailSmarter Planet: Rail
Smarter Planet: Rail
 
IBM zEnterprise: Distribution
IBM zEnterprise: DistributionIBM zEnterprise: Distribution
IBM zEnterprise: Distribution
 
IBM zEnterprise: Banking
IBM zEnterprise: BankingIBM zEnterprise: Banking
IBM zEnterprise: Banking
 
IBM zEnterprise: Retail
IBM zEnterprise: RetailIBM zEnterprise: Retail
IBM zEnterprise: Retail
 
Smarter Planet: Media and Entertainment
Smarter Planet: Media and EntertainmentSmarter Planet: Media and Entertainment
Smarter Planet: Media and Entertainment
 
Smarter Planet: Transportation
Smarter Planet: TransportationSmarter Planet: Transportation
Smarter Planet: Transportation
 
Smarter Planet: Retail
Smarter Planet: RetailSmarter Planet: Retail
Smarter Planet: Retail
 
Smarter planet: Energy and Utilities
Smarter planet: Energy and UtilitiesSmarter planet: Energy and Utilities
Smarter planet: Energy and Utilities
 
Smarter planet: Healthcare
Smarter planet: HealthcareSmarter planet: Healthcare
Smarter planet: Healthcare
 
Smarter planet: Food supply
Smarter planet: Food supplySmarter planet: Food supply
Smarter planet: Food supply
 
Smarter planet: Government
Smarter planet: GovernmentSmarter planet: Government
Smarter planet: Government
 
Smarter planet: Automotive
Smarter planet: AutomotiveSmarter planet: Automotive
Smarter planet: Automotive
 
Smarter Planet: Airlines
Smarter Planet: AirlinesSmarter Planet: Airlines
Smarter Planet: Airlines
 
Smarter Computing Big Data
Smarter Computing Big DataSmarter Computing Big Data
Smarter Computing Big Data
 

Kürzlich hochgeladen

Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsIntellect Design Arena Ltd
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfHajeJanKamps
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfSourav Sikder
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZKanakChauhan5
 
Developing Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursDeveloping Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursKaiNexus
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsP&CO
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato pptElizangelaSoaresdaCo
 
Tata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakTata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakEditores1
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBBPMedia1
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsyasinnathani
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyHanna Klim
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examplesamberjiles31
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Onlinelng ths
 
NASA CoCEI Scaling Strategy - November 2023
NASA CoCEI Scaling Strategy - November 2023NASA CoCEI Scaling Strategy - November 2023
NASA CoCEI Scaling Strategy - November 2023Steve Rader
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGlokeshwarmaha
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinAnton Skornyakov
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentationbaron83
 
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView
 

Kürzlich hochgeladen (20)

Upgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking ApplicationsUpgrade Your Banking Experience with Advanced Core Banking Applications
Upgrade Your Banking Experience with Advanced Core Banking Applications
 
PDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdfPDT 88 - 4 million seed - Seed - Protecto.pdf
PDT 88 - 4 million seed - Seed - Protecto.pdf
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdfChicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
Chicago Medical Malpractice Lawyer Chicago Medical Malpractice Lawyer.pdf
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZ
 
Developing Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, OursDeveloping Coaching Skills: Mine, Yours, Ours
Developing Coaching Skills: Mine, Yours, Ours
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizations
 
Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato ppt
 
Tata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerakTata Kelola Bisnis perushaan yang bergerak
Tata Kelola Bisnis perushaan yang bergerak
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
 
Data skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story pointsData skills for Agile Teams- Killing story points
Data skills for Agile Teams- Killing story points
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agency
 
Intellectual Property Licensing Examples
Intellectual Property Licensing ExamplesIntellectual Property Licensing Examples
Intellectual Property Licensing Examples
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Online
 
NASA CoCEI Scaling Strategy - November 2023
NASA CoCEI Scaling Strategy - November 2023NASA CoCEI Scaling Strategy - November 2023
NASA CoCEI Scaling Strategy - November 2023
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup Berlin
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentation
 
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
TalentView Webinar: Empowering the Modern Workforce_ Redefininig Success from...
 

Smarter Planet: Life Sciences

  • 1. George Mattathil - 5/17/2011 Let’s Build A Smarter Planet: What will it mean for Life Sciences? © 2010 IBM Corporation
  • 2. The reality of living in a globally integrated world is upon us.  Safety, quality, efficacy of products is challenged more than ever before  Outdated and inefficient (drug) research and development (R&D) has contributed to expiring patents, dry pipelines and cost  Generic alternatives abound as pricing pressures increase  Globalization efforts and the new economic environment have constrained resources The world is connected: economically, socially and technically. © 2010 IBM Corporation
  • 3. The need for progress is clear. 50% 65.2 billion of patients drop out of their Dollars invested in US pharma treatment within the first and biotech R&D in 2008. Only 4 year.20% of prescriptions go truly innovative products were unfilled in hard economic times delivered in the same period.2 and 30% of prescriptions are not refilled.1 90% 74 billion of drugs work in only Dollars US lost due to 30-50% of people3 a 10% counterfeit drug supply4 1 ―ECONOMIC CRISIS : Pharma Sales Will Drop As Patients Cut Back on Prescriptions‖ 2 R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges, March 10, 2009 3 ―Demolished - the myth that allows drugs giants to sell more‖. , The Independent, Dec. 8, 2003. 4 ―Partnership for Safe Medicines Arms Public Against Counterfeit Drugs‖ Dec. 2, 2008 and IBM analysis © 2010 IBM Corporation
  • 4. The opportunity for progress is clear. Better compliance with treatment More innovative discovery & development Smarter Life Sciences: Smarter Life Sciences: Merit Foundation Ecole Polytechnique Federale de Lausanne A Netherlands based non-commercial, international A major Swiss research institute harnesses the medical organization accesses thousands of power of supercomputers to model the human brain, anonymous patient records and monitors patients’ speeding the search for causes and cures of progress and benchmark responses to treatment neurological and psychiatric diseases with the ability against information about others to run simulations in close to real time Improved patient insights Reduced risk from counterfeits Smarter Life Sciences: Smarter Life Sciences: Metabasis therapeutics, Inc. GSMS, Inc. A biopharmaceutical company in the U.S. A small U.S. wholesale pharmaceuticals distributor, speeds time to market for metabolic- and liver- contract manufacturer and packaging company disease therapies deploys a pharmaceutical track and trace solution ahead of the competition The demand for change is strong The 2008 Global CEO Study: ―The Enterprise of the Future‖ © 2010 IBM Corporation
  • 5. The demand for change is strong. LIFE SCIENCES CEO’S GLOBAL CEO’S 8 in 10 Life Sciences leaders anticipate substantial change ahead. 22% Gap between envisioned change and past success at managing it. Change Needed © 2010 IBM Corporation
  • 6. For life sciences companies, this means leading in the face of global challenges brought on by three key drivers while overcoming two key inhibitors. DRIVERS INHIBITORS BETTER UNDERSTANDING OF THE COST AND REVENUE PRESSURES FUNDAMENTALS OF THE DISEASE GROWING RAPIDLY Predictability of a treatment’s efficacy and Restructured business models to safety will drive improved outcomes streamline overall operations including strategic outsourcing, partnering and turning to emerging markets PRODUCT MODELS MOVE TO BIOLOGICS Drugs targeted at a defined population as well as disease-modifying and preventative REGULATORY, POLITICAL AND SOCIETAL in nature PRESSURES INTENSIFYING Legislation is forcing investments in supply chain traceability and promotional DISRUPTIVE SCIENCE AND spending analysis TECHNOLOGY EMERGING Increased use of medical imaging and biomarkers in the move to targeted treatments and personalized medicine © 2010 IBM Corporation
  • 7. A smarter system forges partnerships in order to deliver treatment solutions which are targeted at the individual patient. Smarter Discovery & Development Collaboration with  People and the  Other life sciences organization companies Smarter life  Technology  Biotech sciences  Processes  Medical device organization Smarter Smarter and diagnostic Sales & Supply manufacturers Marketing Chain  Enhanced  Contract communication with organizations end consumer  Academic centers  Compliance  Hospitals / clinics  Patient persistence  Patients  Consumer insights Network of smart partners Patient / consumer insights © 2010 IBM Corporation
  • 8. It’s a new world—and life sciences organizations are key players in an economy that demands increased value, safer solutions, better outcomes, sustainability and accountability. INNOVATE OPERATE EFFECTIVELY Develop new business models to Align and optimize processes to compete more effectively. Fuel support patient centered healthcare innovation in R&D and drive delivery and patient safety to drive greater discovery productivity. better outcomes and an enhanced LIFE experience. SCIENCES ENGAGE Enable life sciences to take an active role in empower a healthier society and patients by collaborating to improve breakthrough therapies. © 2010 IBM Corporation
  • 9. + + = An opportunity for life science organizations to think and act in new ways. Innovate Operate Effectively Engage © 2010 IBM Corporation
  • 10. Smart life sciences: Innovate. SMART IS SMART IS Improving the efficiency of drug discovery Reducing attrition rates and costs and development through to reformulation during discovery by use of high of existing drug products to extend performance computing. product life cycle. SMART IS SMART IS Fueling clinical innovation with much Integrating all relevant data, reproducing more processing power while the control principles of a biological decreasing operating costs. system and simulating how it will respond. © 2010 IBM Corporation
  • 11. Smart life sciences: Operate Effectively. SMART IS SMART IS Combating risk by building Automating baseline activities in the intelligence into both products supply chain increases responsiveness to and packaging. free up time for employees to manage critical exceptions and focus on higher value activities. SMART IS SMART IS Automatically analyzing and correlating Enabling research beyond the current information from multiple sources to ―trial, file, and archive‖ data usage model identify areas of risk and regulatory through clinical & safety data accessible compliance exposures. across studies. © 2010 IBM Corporation
  • 12. Smart life sciences: Engage. SMART IS SMART IS Driving more innovation and short term Identifying actions to stem the impact revenues through collaboration. of chronic diseases like diabetes, heart disease or stroke by modeling disease progression. SMART IS SMART IS Monitoring impending disasters and Building in interconnectivity across a proactively responding so supply of network to provide a hands-on view of targeted treatment is available immediately. the entire supply chain for all parties. © 2010 IBM Corporation
  • 13. Smart life sciences: Innovate. Engage. Ecole Polytechnique Federale de Lausanne (EPFL): Merit Foundation: developed METEOR – Measurement of Embarked on Project Blue Brain, a joint research venture Efficacy of Treatment in the Era of Outcome in with IBM to create a model of the fundamental building Rheumatology – an Internet-based solution that will blocks of the human brain, unprecedented in its scope – revolutionize and improve patient treatment. Clinicians now ultimately generating functional models for 10,000 have access to thousands of anonymous patient records, morphologically complex neurons. covering several countries and many hospitals; they can learn from one another on the best treatment for patients. Innovate.Engage. National Genographic: created a DNA analysis repository that lets researchers and scientists analyze gathered genetic data and identify patterns among the samples. Private citizens can also contribute samples to the DNA repository, hosted in an IBM DB2® data server, and view personalized ancestral migration profiles on the organization’s Web site. This has Establishes one of the largest centralized collections of genetic information, increasing collaboration among scientists and researchers. © 2010 IBM Corporation
  • 14. Operate Effectively. Metabasis Therapeutics: Highly-accurate, first-of-a- Golden State Medical Supply, Inc. (GSMS): kind simulation software significantly lowers drug Implemented the Pharma Track & Trace Solution using discovery time and costs by eliminating 80% of the two-dimensional barcodes, radio frequency compounds to be synthesized and tested in the lab.1 identification (RFID) and other sensors to track product movements. Puts GSMS in an advantageous competitive position by making it one of the first distributors to comply with the new regulations. Fujita Pharmaceutical LTD, Co. : Improved its total Bilcare Limited: Developed a Track-and-Trace project management capabilities. The new solution Solution framework to seamlessly integrated into any helps the company minimize out-of-stock instances supply chain system, providing real-time product by consistently managing sales, production, authentication. The technology helps detect purchases of raw materials and accounting through a counterfeit goods, potentially saving millions of lives single system. © 2010 IBM Corporation
  • 15. Smart life sciences: IBM Research Projects New Intelligence Research Example Smart Work Research Example Protecting the privacy of biometric data by Leveraging Blue Gene for large scale simulation creating an anonymous biometrics recognition in the drug discovery process. system that scales to large populations. Dynamic Infrastructure Research Examples Automatically analyzing and correlating Building governance and maintenance tools to information from multiple sources to identify support benefit configuration, research, and areas of risk and regulatory compliance exposures. correction processes. © 2010 IBM Corporation
  • 16. At the center of smarter life sciencesis an increasingly more networked operation focused on the end patient. IMPROVING COLLABORATING operations internally with other biophamra, academia MEASURING your progress SHARING  IMPROVED PATIENT and plan patient insights INSIGHTS  REDUCED RISK FROM COUNTERFEITS COMPLYING with regulations  BETTER COMPLIANCE WITH TREATMENT  MORE INNOVATIVE MONITORING UNDERSTANDING DISCOVERY & and responding fundamental of the DEVELOPMENT to signals disease CONVERGING INTEGRATING across industries all relevant data both internally and externally The result is also a safe, effective and valued treatment solution targeted at the patient. © 2010 IBM Corporation
  • 17. The imperative for life sciences today is clear. INNOVATE OPERATE EFFECTIVELY ENGAGE  Develop strategies in  Optimize core systems and  Interconnect researchers support of advanced infrastructure to reduce costs from academic, industry and therapies and technologies, and to more flexibly service regulators to bolster product such as gene and cell new business demands pipelines therapies and  Use technology to  Bridge internal silos with nanotechnology communicate, share information better collaboration tools and  Fuel drug discovery by and assist in decision-support infrastructures investing in innovative  Employ a fact-based,  Build an integrated network decision-making quantitative risk management of manufacturing, and approaches approach in the supply chain distribution partners  Maximize development with and by building intelligence into the integration of modeling products and packaging and simulation into new clinical trial programs  Use social networking to connect globally to gather insights to fuel innovation © 2010 IBM Corporation
  • 18. IBM’s solution strategy is aligned with the needs of all stakeholders of the life sciences companies. LIFE SCIENCES SYSTEMS ARE FOCUSED ON… IBM IS INVESTING IN…  Systems biology Innovate and thrive  Nanotechnology  Smarter Analytics & Information Agenda  Clinical decision support systems  Customer segmentation / e-detailing  Business process modeling, analytics and performance management  Life Sciences Hub  Biopartnering strategy  Interoperability Streamline and transform  Medical home: Patient-centered collaborative care  Patient portals  Collaborative platforms & tools  Risk Modeling  Universal Data Model/Warehouse Collaborate and empower  The New Pharma Commercial Model  Marketing and Sales  Regulatory Compliance  Pharmacoviligence  Content Management  Pharma Track and Trace © 2010 IBM Corporation
  • 19. We’ve only just begun to uncover what is possible on a smarter planet.  The world will continue to become smaller, flatter and smarter. We are moving into the age of the globally integrated and intelligent economy, society and planet.  To thrive in a smarter planet, life sciences organizations need to transform so they are more streamlined internally and collaborating effectively externally to deliver more innovative products. There’s no better time to start building a smarter life sciences industry to provide more patient-centric treatment for society. Let’s work together to drive real progress in our world. © 2010 IBM Corporation
  • 20. Trademarks and notes IBM Corporation 2009  IBM, the IBM logo and ibm.com are registered trademarks, and other company, product or service names may be trademarks or service marks of International Business Machines Corporation in the United States, other countries, or both. A current list of IBM trademarks is available on the Web at ―Copyright and trademark information‖ at www.ibm.com/legal/copytrade.shtml  Adobe, the Adobe logo, PostScript, the PostScript logo, Cell Broadband Engine, Intel, the Intel logo, Intel Inside, the Intel Inside logo, Intel Centrino, the Intel Centrino logo, Celeron, Intel Xeon, Intel SpeedStep, Itanium, IT Infrastructure Library, ITIL, Java and all Java-based trademarks, Linux, Microsoft, Windows, Windows NT, the Windows logo, and UNIX are trademarks or service marks of others as described under ―Special attributions‖ at: http://www.ibm.com/legal/copytrade.shtml#section-special  Other company, product and service names may be trademarks or service marks of others.  References in this publication to IBM products or services do not imply that IBM intends to make them available in all countries in which IBM operates. © 2010 IBM Corporation